Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-27
2009-06-30
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S371000
Reexamination Certificate
active
07553838
ABSTRACT:
The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
REFERENCES:
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5389648 (1995-02-01), Tsuboi et al.
patent: 5391560 (1995-02-01), Fuchs et al.
patent: 0 537 580 (1992-05-01), None
patent: WO 01/32173 (2001-05-01), None
patent: WO 01/56993 (2001-08-01), None
patent: WO 02/46129 (2002-06-01), None
S. K. Tahir, et al., Cancer Research, 61, pp. 5480-5485 (2001).
B. G. Szczepankiewicz, et al., J. Med. Chem, 44, pp. 4416-4430 (2001).
A. Attia, et al, Pharmazie 37, H.8, pp. 551-553 (1982).
F. Manna, et al., Bio. & Med. Chem. Ltrs, 12, pp. 3629-3633 (2002).
C. Safak, et al., J. Indian Chem. Soc., vol. 67, pp. 571-574 (1990).
U. Bauer, et al., Tetrahedron Letters, vol. 41, No. 15, pp. 2713-2717 (2000).
Fraley Mark E.
Hartman George D.
Beeler Nicole M.
Habte Kahsay T
Merck & Co. , Inc.
Muthard David A.
LandOfFree
Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064781